A Single and Multiple Dose Study of PF-05221304 in Healthy Japanese Adults

NCT03597217 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-05221304
DRUG: PF-05221304
DRUG: Placebo

Sponsor

Pfizer